Gynaecomastia linked to the intake of a herbal supplement fortified with diethylstilbestrol

Food Additives and Contaminants - Part A

Volumn 27, Issue 7, 2010, Pages 917-925

  Toorians, A W F T ^a   Bovee, T F H ^b   de Rooy, J ^a   Stolker, L A A M ^b   Hoogenboom, R L A P ^b  

^a ST ANNA HOSPITAL   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Bioassay; Clinical study; Dietary supplements; Hormones; Liquid chromatography mass spectrometry (LC MS); Nutritional supplements; Toxicology

Indexed keywords

DIETHYLSTILBESTROL; ENHANCED GREEN FLUORESCENT PROTEIN; ESTRADIOL; ESTROGEN; ESTRONE; HERBACEOUS AGENT; TESTOSTERONE; ANDROGEN; PLANT MEDICINAL PRODUCT; SEX HORMONE;

ADULT; ARTICLE; BLOOD EXAMINATION; CASE REPORT; DIET SUPPLEMENTATION; GYNECOMASTIA; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME OF FLIGHT MASS SPECTROMETRY; BIOASSAY; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; DOSE RESPONSE; DRUG CONTAMINATION; DRUG EFFECTS; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROSTATIC HYPERPLASIA; SELF MEDICATION; YEAST;

ANDROGENS; BIOLOGICAL ASSAY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETHYLSTILBESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CONTAMINATION; ESTROGENS; ESTROGENS, NON-STEROIDAL; GONADAL STEROID HORMONES; GYNECOMASTIA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PLANT PREPARATIONS; PROSTATIC HYPERPLASIA; SELF MEDICATION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; YEASTS;

EID: 77953643788     PISSN: 19440049     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/19440041003660869     Document Type: Article

References (27)

1. Berges RR, Windeler J, Trampisch HJ, Senge T. 1995. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Betasitosterol Study Group. Lancet. 345:1529-1532.
2. Bovee TFH, Bor G, Heskamp HH, Hoogenboom LAP, Nielen MWF. 2006. Validation and application of a robust yeast estrogen bioassay for the screening of estrogenic activity in animal feed. Food Addit Contam. 23:556-568.
3. Bovee TFH, Helsdingen JR, Rietjens IMCM, Keijer J, Hoogenboom LAP. 2004. Rapid yeast estrogen bioassays stably expressing human estrogen receptors and, and green fluorescent protein: a comparison of different compounds with both receptor types. J Steroid Biochem Mol Biol. 91:99-109.
4. Bovee TFH, Pikkemaat MG. 2009. Bioactivity-based screening of antibiotics and hormones. J Chrom A. 1216: 8035-8050.
5. Bovee TFH, Schoonen WGEJ, Hamers ARM, Jorge Bento M, Peijnenburg AACM. 2008. Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities. Analyt Bioanalyt Chem. 390:1111-1119.
6. Braunstein GD. 2007. Gynecomastia. N Engl J Med. 357:1229-1237.
7. Brawer MK. 2001. The evolution of hormonal therapy for prostatic carcinoma. Rev Urol. 3(3):1-9.
8. Breza J, Dzurny O, Borowka A, Hanus T, Petrik R, Blane G, Chadha-Boreham H. 1998. Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe. Curr Med Res Opin. 14:127-139.
9. Brouwers MM, Feitz WFJ, Roelofs LAJ, Kiemeney LALM, Gier RPE, Roeleveld N. 2006. Hypospadias: a transgenerational effect of diethylstilbestrol? Human Reproduct. 21:666-669.
10. Capodice JL, Katz AE. 2006. What patients take without telling you: holistic approach for BPH (review). World J Urol. 24:378-382.
11. Clement J, Bubley G. 2008. Prostasol and venous thromboembolism. Urology. 72(3):664-666.
12. Colton T, Greenberg ER, Noller K, et al. 1993. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. J Am Med Assoc. 269:2096-2100.
13. Herbst AL, Ulfelder H, Poskanzer DC. 1971. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in Young women. N Engl J Med. 284:878-881.
14. Ismail AA, Barth JH. 2001. Endocrinology of gynaecomastia. Ann Clin Biochem. 38:596-607.
15. Katz AE. 2002. PC-SPES: herbal formulation for prostate cancer - Editorial Comment 2. Urology. 60:377-377.
16. Lommen A, Schilt R, Weseman J, Roos AH, Van Velde JW, Nielen MWF. 2002. Application of 1D 1H NMR for fast non-targeted screening and compositional analysis of steroid cocktails and veterinary drug formulations administered to livestock. J Pharm Biomed Anal. 28:87-96.
17. Malkowicz B. 2002. The role of diethylstilbestrol in the treatment of prostate cancer. Urology. 58:108-113.
18. McLeod DG, Iversen P. 2000. Gynecomastia in patients with prostate cancer: a review of treatment options. Urology. 56:713-720.
19. Montgomery RB, Nelson PS, Lin D, Ryan CW, Garzotto M, Beer TM. 2007. Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancer. Cancer. 110:996-1002.
20. Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, et al. 2004. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J Clin Oncol. 22:3705-3712.
21. Palmer JR, Wise LA, Hatch EE, Troisi R, Titus-Ernstoff L, Strohsnitter W, Kaufman R, Herbst AL, Noller KL, Hyer M, et al. 2006. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarker Prev. 15:1509-1514.
22. Rohrich RJ, Ha RY, Kenkel JM, Adams WP Jr. 2003. Classification and management of gynecomastia: defining the role of ultrasound assisted liposuction. Plastic Reconstruct Surg. 111:909-923.
23. Sang SM, Liu ZH, Rosen RT, Ho CT. 2006. Bioassay-guided isolation, identification, and quantification of the estrogen-like constituent from PCSPES. In: Herbs: Challenges in chemistry and biology. ACS Symposium Series 925. p. 117-125.
24. Vermeulen A, Verdonck L, Kaufman JM. 1999. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 843:666-3672.
25. Wilcox AJ, Baird DD, Weinberg CR, Hornsby PP, Herbst AL. 1995. Fertility in men exposed prenatally to diethylstilbestrol. New Engl J Med. 332:1411-1416.
26. Wortsman J, Hamidinia A, Winters SJ. 1989. Hypogonadism following long-term treatment with diethylstilbestrol. Am J Med Sci. 297:365-368.
27. Yuan H, Gong A, Young CY. 2005. Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells. Carcinogenesis. 26:793-801.